Jardiance® decreased relative risk of hospitalization for heart failure by 50% versus DPP-4 inhibitors and by 30% versus GLP-1 receptor agonists in adults with type 2 diabetes in real-world evidence study ...Middle East

Jardiance showed a reduction in relative risk of all-cause mortality by 40% compared with DPP-4 inhibitors in the subset of people with Medicare coverage Data from these final analyses of EMPRISE complements findings from the landmark EMPA-REG OUTCOME® trial RIDGEFIELD, Conn. and...

Hence then, the article about jardiance decreased relative risk of hospitalization for heart failure by 50 versus dpp 4 inhibitors and by 30 versus glp 1 receptor agonists in adults with type 2 diabetes in real world evidence study was published today ( Sunday 05/06/2022 - 11:48 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Jardiance® decreased relative risk of hospitalization for heart failure by 50% versus DPP-4 inhibitors and by 30% versus GLP-1 receptor agonists in adults with type 2 diabetes in real-world evidence study )

Also on site :

• Man arrested on suspicion of fatal shooting in Huntington Beach
• Trump refuses ‘to think purely of peace’
• Danish authorities banned from using Bluetooth at work – media